T2 mapping of molecular subtypes of WHO grade II/III gliomas
Abstract Background According to the new WHO classification from 2016, molecular profiles have shown to provide reliable information about prognosis and treatment response. The purpose of our study is to evaluate the diagnostic potential of non-invasive quantitative T2 mapping in the detection of ID...
Main Authors: | Maike Kern, Timo Alexander Auer, Thomas Picht, Martin Misch, Edzard Wiener |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-019-1590-1 |
Similar Items
-
DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas
by: Yashna Paul, et al.
Published: (2017-04-01) -
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas
by: Yu-An Zhang, et al.
Published: (2016-11-01) -
Brainstem Glioma in Adults
by: Jethro Hu, et al.
Published: (2016-08-01) -
Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival
by: Peng-Fei Wang, et al.
Published: (2018-08-01) -
The Role of ATRX in Glioma Biology
by: Pravanya Nandakumar, et al.
Published: (2017-09-01)